Clinical trials
Phase 3 Dementia trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 3 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 7 |
| Active, not recruiting | 5 |
| Completed | 5 |
| Recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 3 |
| FORUM Pharmaceuticals Inc | 3 |
| TauRx Therapeutics Ltd | 3 |
| Eli Lilly and Company | 2 |
| AstraZeneca | 1 |
| Axovant Sciences Ltd. | 1 |
| Bayside Health | 1 |
| Eisai Co., Ltd. | 1 |
| Eisai Inc. | 1 |
| Garvan Institute of Medical Research | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dementia | 20 |
| Alzheimer Disease | 18 |
| Cognitive Dysfunction | 7 |
| Neurodegenerative Diseases | 7 |
| Brain Diseases | 6 |
| Central Nervous System Diseases | 3 |
| Mental Disorders | 3 |
| Nervous System Diseases | 3 |
| Neurocognitive Disorders | 3 |
| Tauopathies | 3 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.